PRESS-RELEASE ·Filed Oct 21, 2026
Press release · Earnings
Latest settled — T+1d
CTKB ▲ +2.95% at T+1d
NEUTRAL call +2.95% · α vs SPY +3.47% · entry $5.43 → $5.59
T+1d
+2.95%
call +2.95% · α +3.47%
$5.59
settled 6d ago
T+5d
Pending
in 8h
T+20d
Pending
in 21d
T+60d
Pending
in 3mo
Price Chart
Loading chart...
Executive Summary
Cytek Biosciences, Inc. announced it will report its Q3 2026 results on November 4, 2026.
Key Facts
- Cytek Biosciences, Inc. announced it will report its Q3 2026 results on November 4, 2026.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3385880 |
8 reports for CTKB
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 6d ago | Press Release | $5.43 | awaiting T+20 | — | $5.98 (+10.13%) |
Sep 22, 2026 5w ago | Institutional Cluster | $5.71 $5.34 | ▼ −6.48% | ▼ −5.92% | $5.98 (+4.73%) |
Aug 24, 2026 9w ago | 8-K | $4.44 $5.71 | ▼ −28.60% | ▼ −27.29% | $5.98 (−34.68%) |
Jun 25, 2026 17w ago | 8-K | $4.48 $4.56 | ▲ +1.79% | ▲ +0.53% | $5.98 (+33.48%) |
Jun 12, 2026 19w ago | 3 | $3.93 $4.51 | ▲ +14.76% | ▲ +15.51% | $5.98 (+52.16%) |
Jun 11, 2026 19w ago | Institutional Cluster | $4.02 $4.59 | ▼ −14.18% | ▼ −12.29% | $5.98 (−48.76%) |
Jun 2, 2026 21w ago | 8-K | $4.05 $4.59 | ▲ +13.33% | ▲ +14.33% | $5.98 (+47.65%) |
Apr 28, 2026 26w ago | DEFA14A | $4.44 $4.12 | ▼ −7.21% | ▼ −13.26% | $5.98 (+34.68%) |
Showing 8 of 8
US Market Status
Market Closed — Opens in 9h 25m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers